Vanguard Group Inc Aura Biosciences, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,805,434 shares of AURA stock, worth $14.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,805,434

Previous 1,767,410 2.15%

Holding current value

$14.7 Million

Previous $13.4 Million 20.4%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.9 - $10.36 $262,365 - $393,928	38,024 Added 2.15%	1,805,434 $16.1 Million
Q2 2024 Aug 13, 2024	BUY	$6.81 - $7.89 $544,800 - $631,200	80,000 Added 4.74%	1,767,410 $13.4 Million
Q1 2024 May 10, 2024	SELL	$7.09 - $9.24 $305,018 - $397,514	-43,021 Reduced 2.49%	1,687,410 $13.2 Million
Q4 2023 Feb 14, 2024	BUY	$7.02 - $11.98 $4.91 Million - $8.38 Million	699,337 Added 67.82%	1,730,431 $15.3 Million
Q3 2023 Nov 14, 2023	BUY	$8.97 - $12.38 $26,210 - $36,174	2,922 Added 0.28%	1,031,094 $9.25 Million
Q2 2023 Aug 14, 2023	SELL	$8.51 - $13.33 $173,731 - $272,131	-20,415 Reduced 1.95%	1,028,172 $12.7 Million
Q1 2023 May 15, 2023	BUY	$8.88 - $12.11 $1.64 Million - $2.24 Million	185,007 Added 21.42%	1,048,587 $9.73 Million
Q4 2022 Feb 10, 2023	BUY	$9.86 - $14.59 $2.54 Million - $3.76 Million	257,696 Added 42.53%	863,580 $9.07 Million
Q3 2022 Nov 14, 2022	BUY	$13.1 - $20.34 $2.24 Million - $3.47 Million	170,709 Added 39.23%	605,884 $11 Million
Q2 2022 Aug 12, 2022	BUY	$12.37 - $21.86 $2.55 Million - $4.52 Million	206,542 Added 90.34%	435,175 $6.17 Million
Q1 2022 May 13, 2022	BUY	$15.94 - $23.34 $37,857 - $55,432	2,375 Added 1.05%	228,633 $5.03 Million
Q4 2021 Feb 14, 2022	BUY	$14.76 - $24.89 $3.34 Million - $5.63 Million	226,258 New	226,258 $3.84 Million

Others Institutions Holding AURA

# of Institutions

Shares Held

37.6M

Call Options Held

122K

Put Options Held

38.5K

View Full List

About Aura Biosciences, Inc.

Ticker AURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,273,600
Market Cap $238M
Description
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...

More about AURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Aura Biosciences, Inc. Transaction History